» Articles » PMID: 35314870

Mortality Trends in Type 1 Diabetes: a Multicountry Analysis of Six Population-based Cohorts

Abstract

Aims/hypothesis: Mortality has declined in people with type 1 diabetes in recent decades. We examined how the pattern of decline differs by country, age and sex, and how mortality trends in type 1 diabetes relate to trends in general population mortality.

Methods: We assembled aggregate data on all-cause mortality during the period 2000-2016 in people with type 1 diabetes aged 0-79 years from Australia, Denmark, Latvia, Scotland, Spain (Catalonia) and the USA (Kaiser Permanente Northwest). Data were obtained from administrative sources, health insurance records and registries. All-cause mortality rates in people with type 1 diabetes, and standardised mortality ratios (SMRs) comparing type 1 diabetes with the non-diabetic population, were modelled using Poisson regression, with age and calendar time as quantitative variables, describing the effects using restricted cubic splines with six knots for age and calendar time. Mortality rates were standardised to the age distribution of the aggregate population with type 1 diabetes.

Results: All six data sources showed a decline in age- and sex-standardised all-cause mortality rates in people with type 1 diabetes from 2000 to 2016 (or a subset thereof), with annual changes in mortality rates ranging from -2.1% (95% CI -2.8%, -1.3%) to -5.8% (95% CI -6.5%, -5.1%). All-cause mortality was higher for male individuals and for older individuals, but the rate of decline in mortality was generally unaffected by sex or age. SMR was higher in female individuals than male individuals, and appeared to peak at ages 40-70 years. SMR declined over time in Denmark, Scotland and Spain, while remaining stable in the other three data sources.

Conclusions/interpretation: All-cause mortality in people with type 1 diabetes has declined in recent years in most included populations, but improvements in mortality relative to the non-diabetic population are less consistent.

Citing Articles

Can Islet Transplantation Possibly Reduce Mortality in Type 1 Diabetes.

Isenberg J, Kandeel F Cell Transplant. 2025; 34():9636897241312801.

PMID: 39831598 PMC: 11748148. DOI: 10.1177/09636897241312801.


The epidemiology of type 1 diabetes mellitus in older adults.

Tomic D, Harding J, Jenkins A, Shaw J, Magliano D Nat Rev Endocrinol. 2024; 21(2):92-104.

PMID: 39448829 DOI: 10.1038/s41574-024-01046-z.


Determinants of vascular impairment in type 1 diabetes-impact of sex and connexin 37 gene polymorphism: A cross-sectional study.

Pithova P, Cichrova M, Kvapil M, Hubacek J, Dlouha D, Pitha J Cardiovasc Diabetol. 2024; 23(1):309.

PMID: 39175027 PMC: 11342627. DOI: 10.1186/s12933-024-02401-0.


Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity.

Fang M, Wang D, Selvin E JAMA. 2024; 331(16):1411-1413.

PMID: 38573653 PMC: 11040401. DOI: 10.1001/jama.2024.2103.


The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial.

Sterner Isaksson S, Olafsdottir A, Ivarsson S, Imberg H, Toft E, Hallstrom S Lancet Reg Health Eur. 2024; 37:100799.

PMID: 38362553 PMC: 10866914. DOI: 10.1016/j.lanepe.2023.100799.


References
1.
Capewell S, Morrison C, McMurray J . Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999; 81(4):380-6. PMC: 1729021. DOI: 10.1136/hrt.81.4.380. View

2.
Ford E, Ajani U, Croft J, Critchley J, Labarthe D, Kottke T . Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356(23):2388-98. DOI: 10.1056/NEJMsa053935. View

3.
Jorgensen M, Almdal T, Carstensen B . Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia. 2013; 56(11):2401-4. DOI: 10.1007/s00125-013-3025-7. View

4.
Harding J, Shaw J, Peeters A, Davidson S, Magliano D . Age-Specific Trends From 2000-2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People. Diabetes Care. 2016; 39(6):1018-26. DOI: 10.2337/dc15-2308. View

5.
Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson A, Miftaraj M . Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med. 2017; 376(15):1407-1418. DOI: 10.1056/NEJMoa1608664. View